We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001012 [RNA polymerase II regulatory region DNA binding] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001228 [transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding] GO:0001890 [placenta development] GO:0002021 [response to dietary excess] GO:0002024 [diet induced thermogenesis] GO:0002674 [negative regulation of acute inflammatory response] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007507 [heart development] GO:0007584 [response to nutrient] GO:0008134 [transcription factor binding] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0008285 [negative regulation of cell proliferation] GO:0009409 [response to cold] GO:0009612 [response to mechanical stimulus] GO:0010033 [response to organic substance] GO:0010467 [gene expression] GO:0010468 [regulation of gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0014070 [response to organic cyclic compound] GO:0015909 [long-chain fatty acid transport] GO:0019216 [regulation of lipid metabolic process] GO:0019395 [fatty acid oxidation] GO:0019899 [enzyme binding] GO:0019903 [protein phosphatase binding] GO:0030224 [monocyte differentiation] GO:0030308 [negative regulation of cell growth] GO:0030331 [estrogen receptor binding] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0031000 [response to caffeine] GO:0031100 [organ regeneration] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0032966 [negative regulation of collagen biosynthetic process] GO:0033189 [response to vitamin A] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0035902 [response to immobilization stress] GO:0036270 [response to diuretic] GO:0042493 [response to drug] GO:0042593 [glucose homeostasis] GO:0042594 [response to starvation] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043065 [positive regulation of apoptotic process] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0043627 [response to estrogen] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045444 [fat cell differentiation] GO:0045598 [regulation of fat cell differentiation] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046321 [positive regulation of fatty acid oxidation] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048471 [perinuclear region of cytoplasm] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0048714 [positive regulation of oligodendrocyte differentiation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0050873 [brown fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0051974 [negative regulation of telomerase activity] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060100 [positive regulation of phagocytosis, engulfment] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0071285 [cellular response to lithium ion] GO:0071300 [cellular response to retinoic acid] GO:0071306 [cellular response to vitamin E] GO:0071379 [cellular response to prostaglandin stimulus] GO:0071380 [cellular response to prostaglandin E stimulus] GO:0071407 [cellular response to organic cyclic compound] GO:0071455 [cellular response to hyperoxia] GO:0090575 [RNA polymerase II transcription factor complex] GO:1901558 [response to metformin] GO:2000230 [negative regulation of pancreatic stellate cell proliferation]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0030522 [intracellular receptor signaling pathway]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006351 [transcription, DNA-templated] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006351 [transcription, DNA-templated] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043565 [sequence-specific DNA binding]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0030522 [intracellular receptor signaling pathway]